Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
about
The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1aMechanisms involved in antibody- and complement-mediated allograft rejectionModeling human arthritic diseases in nonhuman primates.Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesEndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgGThe p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodiesHuman IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysisEnzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathyPairing of oligosaccharides in the Fc region of immunoglobulin G.IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.Mechanisms of action of intravenous immunoglobulins.Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort studyDoes it take sugar? A clinical role for measuring the glycosylation of IgG?Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.Mechanisms of Autoantibody-Induced Pathology.Glycobiology: 'the function of sugar in the IgG molecule'.Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypesAberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changesReversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.Fc-glycosylation of IgG1 is modulated by B-cell stimuli.The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus.Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccinationMultiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylationHypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritisCharacterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis.Sialylation determines the nephritogenicity of IgG3 cryoglobulins.Carbohydrate recognition systems in autoimmunity.Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation.T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodiesFibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.
P2860
Q24307879-77DEE6F6-DEA3-4C3E-BFC0-85644DDFFA52Q24629268-9AFC3567-16BF-49CA-AF7A-8754C0F478B2Q24810445-6008C5FA-3B47-40DD-AC2B-B6D030678832Q28069362-BDB65A27-886F-4F21-887C-60F681A9A5A6Q28366792-05B29B45-5506-44D1-80E7-4D0C2F5C0C60Q28368414-9B4B10E6-ECA3-4571-8741-62D1756EC8F7Q28471918-59D281DC-0F2F-4793-8A2C-8259435E332FQ28539595-B2AA8267-55FC-44EE-9040-6CD7908E3ECDQ30872201-4027B706-53E4-41B2-8301-CE298249A9FCQ33378924-F50B1FAF-29DE-4EC1-BC3B-3163A9C0158BQ33389428-2C5B80B4-DB9A-4727-83A6-F2A5BB57A874Q33518916-6FB7D1B7-A089-4A51-B809-07D50040DAE9Q33578297-35CBEA7E-6260-4ABD-8FAA-7BEF30D12E7CQ33694522-F7EF666A-6333-45BF-84BE-C14BCC8FDDE4Q33740580-9A6F43A2-A5CB-44AD-BBAD-79AA62E71C11Q33881328-44099700-FBAE-44B9-8FCB-B0C493237E28Q33956556-1777E1B8-206F-48F1-BC7E-7B840F87E924Q33986960-E66226A1-01BE-45F2-B865-EA07ACD2283BQ34320745-ADA49F51-A203-4EDE-992D-655BFCD81454Q34468348-E7A5ACBD-D4A5-4257-8725-819E7B880F6DQ34555935-814B494B-5506-4ACE-B49D-480824A539E6Q34772586-7AE9E01D-109A-4FB1-AE3D-CA24CA7D98F2Q34869928-E13F5C18-E064-4A35-981C-A0F81219DDEAQ34994340-A7C223C1-35A3-406F-BD63-83D7F765626CQ35216978-0C9CD84B-4441-421B-8F34-F0E76A46BF37Q35415687-51A28127-EF5C-4085-912A-2C40416CC5F7Q35850207-09865B31-21E2-48AF-82D6-1273341F380DQ35873009-B5F9A5A7-8D31-404A-B595-DE59628F62F2Q35878770-D0FF0639-3480-4291-B96C-FFE96EBE8502Q36195303-BC41BF62-A056-4C96-9B6D-C35FD62A98D0Q36245665-F050F6E4-A902-4D57-A3DE-1E999E722727Q36342795-C736A25D-5278-4154-859C-3AB9343C8D67Q36352180-E839E906-59D6-4E5D-9FAE-7589462EB7AEQ36687913-FF0D2DC2-9FB2-4A7F-A024-379F8BC113EDQ36718541-92F51D40-2B11-4184-B260-938AFDDF8D70Q36768842-E6AB7FFA-8038-47BF-B6AB-748F80A21078Q37066000-078D00B7-54A3-43AD-B46D-6F3480EFBC87Q37123859-3B2B796D-34E3-47C4-B23A-862ADEE5BE66Q37311301-28494FBD-F26B-4B8F-AEB7-DE0FF5545D22Q37319631-D19C4F60-705F-4191-A9CA-B1C4CDE6F482
P2860
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@ast
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@en
type
label
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@ast
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@en
prefLabel
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@ast
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@en
P2093
P2860
P356
P1476
Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
@en
P2093
Rademacher TW
Williams P
P2860
P304
P356
10.1073/PNAS.91.13.6123
P407
P577
1994-06-01T00:00:00Z